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Males and females are known to have gender-specific differences in their immune 
system and gut microbiota composition. Whether these differences in gut microbiota 
composition are a cause or consequence of differences in the immune system is not 
known. To investigate this issue, gut microbiota from conventional males or females was 
transferred to germ-free (GF) animals of the same or opposing gender. We demonstrate 
that microbiota-independent gender differences in immunity are already present in GF 
mice. In particular, type I interferon signaling was enhanced in the intestine of GF females. 
Presumably, due to these immune differences bacterial groups, such as Alistipes, 
Rikenella, and Porphyromonadaceae, known to expand in the absence of innate immune 
defense mechanism were overrepresented in the male microbiota. The presence of 
these bacterial groups was associated with induction of weight loss, inflammation, and 
DNA damage upon transfer of the male microbiota to female GF recipients. In summary, 
our data suggest that microbiota-independent gender differences in the immune system 
select a gender-specific gut microbiota composition, which in turn further contributes to 
gender differences in the immune system.
Keywords: gender, gut microbiota, germ-free mice, immunity, inflammation
inTrODUcTiOn
It is widely accepted that there are differences in the immune system between males and females. 
Males are generally more susceptible to infections (1), whereas prevalence of various autoimmune 
disorders is much higher in females (2, 3). Different concentrations of sex steroids, such as testoster-
one, estrogens, and progesterone, could contribute to these immune differences, since sex steroids 
can influence the function of immune cells by binding to specific receptors expressed on these cells 
(1). Genetic differences between males and females are also considered to contribute, since the X 
chromosome is known to contain the largest number of genes involved in immunity of the whole 
genome (4, 5).
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A third factor that could contribute to gender differences in 
the immune system is the gut microbiota. Our intestine harbors 
a highly complex community of bacteria, which is separated from 
a large pool of immune cells by only a single layer of epithelial 
cells (6). Consequently, gut microbiota composition shapes the 
immune system and vice versa (7). Several studies have shown that 
gut microbiota composition differs between males and females 
(8–11), which could potentially contribute to the observed 
gender-specific differences in immunity. The importance of these 
differences for gender-specific disease development has been 
shown in type 1 diabetes in which a higher prevalence of the 
disease in females was shown to be critically dependent on the gut 
microbiota (10, 11), demonstrating a link between gut microbes, 
gender, and immunity. However, whether gender-dependent 
immunity differences are a cause or consequence of an altered 
gut microbiota composition is not clear.
To determine the contribution of the gut microbiota to 
gender-specific differences in the immune system, in this study, 
we performed gut microbiota transfer experiments from conven-
tional male or female mice to germ-free (GF) recipient mice of 
the same or opposing gender. Effects on the immune system were 
assessed by measuring genome-wide gene expression levels in the 
ileum and by analyzing different immune cell populations in the 
thymus, spleen, mesenteric lymph nodes (MLNs), and Peyer’s 
patches (PPs).
MaTerials anD MeThODs
Mice
Female and male C57BL/6JRccHsd conventional 7- to 10-week- 
old mice were purchased from a commercial supplier (Envigo, 
Horst, the Netherlands). Female and male GF mice, 12- to 
14-weeks old, were obtained from a breeding colony at the 
animal facility of Radboud University Nijmegen Medical Centre 
(Nijmegen, the Netherlands). All animals were put on an 
autoclaved rat/mouse maintenance V153X R/M-H diet (Ssniff, 
Soest, Germany) directly after weaning in the case of GF mice, or 
directly after arrival in the case of conventional mice. The mice 
were kept on this diet throughout the experiment. Conventional 
mice were housed in IVC cages and GF mice were housed in 
GF isolators. All experiments were approved by the local ethical 
committee of the University of Groningen.
experimental Design
After an acclimatization period of at least 4  weeks, feces were 
freshly collected from the conventional males (n = 8) or conven-
tional females (n = 10). Feces from the same group was pooled 
and mixed in PBS. Next, 200  µl of 100  mg/ml of this mixture 
was given by oral gavage to age-matched GF mice of the same or 
opposing gender (n = 10 per experimental group). After transfer, 
recipient mice were individually housed in IVC cages for another 
4 weeks. As a control, male and female GF mice (n = 5) were kept 
germ free throughout the experiment. In summary, there were 
the following experimental groups:
 1. Conventional males (n = 8)
 2. Conventional females (n = 10)
 3. GF males that received microbiota from conventional males 
(n = 10)
 4. GF females that received microbiota from conventional 
females (n = 10)
 5. GF males that received microbiota from conventional females 
(n = 10)
 6. GF females that received microbiota from conventional 
females (n = 10)
 7. GF males as a control (n = 5)
 8. GF females as a control (n = 5)
Organ and Tissue collection
Mice were sacrificed at the following ages: conventional mice 
16–19  weeks, GF recipient mice 16–18  weeks, and GF mice 
13–15  weeks. The GF control mice were slightly younger than 
the other groups of mice since it was logistically not feasible to 
obtain enough GF mice of the same age of both sexes from our 
breeding colony at the same time. Mice were anesthetized with 
isoflurane, bled, and sacrificed by cervical dislocation. Serum 
was collected and stored at −80°C. Colon content and a piece of 
terminal ileum were snap frozen in liquid nitrogen and stored 
at −80°C. In addition, spleen, thymus, PPs, and MLNs were col-
lected for FACS analysis.
Flow cytometry
Single cell suspensions were obtained from spleen, thymus, PPs, 
and MLNs. Cells were stained with Fixable Viability Dye eFluor 
506 (eBioscience, Vienna, Austria) for exclusion of dead cells. 
A-specific binding to Fc receptors was blocked by incubating the 
cells with anti-CD16/32 for 15 min on ice. For extracellular stain-
ing, cells were incubated with the desired mixture of antibodies 
for 30  min on ice. After washing, cells were fixed with FACS 
lysing solution (BD Biosciences, Breda, the Netherlands). For 
intracellular staining, fixed cells were permeabilized with PERM 
(eBioscience, Vienna, Austria) and subsequently stained with the 
desired antibodies for 30 min on ice. For identification of the dif-
ferent T helper (Th) cell subsets, cells were stained with antibodies 
against CD3e (clone 17  A2), CD4 (clone GK1.5), T-bet (clone 
4B10), RORyt (clone B2D), Gata-3 (clone TWAJ), CD25 (clone 
PC61), and Foxp3 (clone FJK-16S). Appropriate isotype controls 
were used to determine specificity of the staining. T cell precur-
sors in thymus were identified by excluding other lineages: CD11b 
(clone M1/70), CD11c (clone HL3), CD19 (clone 1D3), CD45R/
B220 (clone RA3-6B2), NK1.1 (clone PK136), and TER119 
(clone TER-119). Next, cells were gated on populations that were 
double negative (DN), single positive, or double positive for CD4 
(clone GK1.5) and CD8a (clone 53-6.7). To identify earliest T cell 
precursors (triple negative), cells positive for CD3e (clone 145-
2C11) were excluded. Samples were acquired with the FACSVerse 
or FACSCanto II (BD Biosciences, Breda, the Netherlands) and 
analyzed with FlowJo software (FlowJo, LLC, OR, USA).
Transcriptome Microarray
A piece of terminal ileum from each mouse was snap frozen in 
liquid nitrogen and stored afterward at −80°C. RNA was isolated 
with the RNeasy kit (Qiagen, Valencia, CA, USA). Quantity of 
RNA was measured with the ND-1000 (NanoDrop Technologies, 
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Thermo Fisher Scientific, Breda, the Netherlands) and quality 
of RNA was assessed with the Bioanalyzer 2100 (Agilent, Santa 
Clara, CA, USA). Total RNA (100 ng) was labeled utilizing the 
Ambion WT Expression kit (Life Technologies Ltd., Bleiswijk, 
the Netherlands) and the Affymetrix GeneChip WT Terminal 
Labeling kit (Affymetrix, Santa Clara, CA, USA). After labeling, 
samples were hybridized to Affymetrix GeneChip Mouse Gene 
1.1 ST arrays. An Affymetrix GeneTitan Instrument was used 
for hybridization, washing, and scanning of the array plates. 
Bioconductor packages integrated in an online pipeline were used 
for quality control of the data (12, 13). Probe sets were redefined 
using current genome information (14). Probes were reorganized 
based on the Entrez Gene database (remapped CDF v14.1.1). 
Robust Multi-array Analysis preprocessing algorithm available 
in the Bioconductor library affyPLM (15) was used to obtain 
normalized expression estimates from the raw intensity values.
serum antibody isotypes
Mouse serum samples were assayed for mouse IgG1, IgG2a, IgG2b, 
IgG3, IgA, IgE, and IgM using ProcartaPlex Mouse Antibody 
Isotyping Panel on the Luminex platform (Affymetrix, Santa 
Clara, CA, USA), according to manufacturer’s instructions. In 
brief, samples were thawed on ice. Beads were mixed and washed 
and subsequently incubated overnight at 4°C with standards or 
with 1:500 or 1:50,000 diluted samples. After washing, the beads 
were incubated with detection antibody mix for 30 min at room 
temperature. The beads were washed and incubated for 30 min 
at room temperature with streptavidin-PE. After washing the 
beads were measured with a Luminex instrument (Bio-Plex 200, 
Bio-Rad), which was calibrated using Bio-Rad calibration beads. 
Standard curves were calculated using 5-parameter logistic 
regression in Bio-plex 5.0 software.
Microbiota analysis
Fresh feces samples obtained just after defecation were collected 
from all mice at different time points during the experiment. In 
addition, colonic content samples from these mice were collected 
at the end of the experiment. All samples were snap frozen in 
liquid nitrogen and stored at −80°C. These samples were used for 
16S rRNA gene analysis for microbiota profiling with barcoded 
amplicons from the V1–V2 region of 16S rRNA genes generated 
using a 2-step PCR strategy that reduces the impact of barcoded 
primers on the outcome of microbial profiling (16). DNA extrac-
tion was performed using a combination of the bead-beating-plus 
column method and the Maxwell 16 Tissue LEV Total RNA puri-
fication kit (Promega, Leiden, the Netherlands). Beating of the 
fecal pellets took place as described before (17), but with STAR 
(Stool transport and recovery) buffer (Roche, Basel Switzerland). 
250 µl supernatant after centrifugation was taken for the Maxwell 
16 Tissue LEV Total RNA Purification Kit, and the DNA was eluted 
in 50 µl DNAse-free water. Twenty nanograms of DNA were used 
for the amplification of the 16S rRNA gene with primers 27F-DegS 
and 338R I + 338R II for 25 cycles as described before (18), only 
primers had a Universal Tag (UniTag) linkers attached; UniTag 
I (forward) and II (reverses) (I—GAGCCGTAGCCAGTCTGC; 
II—GCCGTGACCGTGACATCG). The first PCR was performed 
in a total volume of 50 µl containing 1× HF buffer (Finnzymes, 
Vantaa, Finland), 1  µl dNTP Mix (10  mM; Promega, Leiden, 
the Netherlands), 1  U of Phusion® Hot Start II High-Fidelity 
DNA polymerase (Finnzymes Vantaa, Finland), 500 nM of the 
27F-DegS primer (18, 19) that was appended with UniTag 1 at 
the 5′ end, 500 nM of an equimolar mix of two reverse primers, 
338R I and II (19) based on three previously published probes 
EUB 338 I, II, and III (18), that were 5′-extended with UniTag 2, 
and 0.2–0.4 ng/µl of template DNA. The sequence of the UniTags 
were selected to have a GC content of ~66% and a minimal 
tendency to form secondary structures, including hairpin loops, 
heterodimers, and homodimers as assessed by the IDTDNA 
Oligoanalyzer 3.1 (Integrated DNA Technologies). Moreover, 
sequences were selected that had no matches in 16S rRNA gene 
databases (based on results of the “TestProbe” tool offered by the 
SILVA rRNA database project (20) using the SSU r117 database), 
and no prefect matches in genome databases with the Primer-
BLAST tool (http://www.ncbi.nlm.nih.gov/tools/primer-blast/). 
The size of the PCR products (~375  bp) was confirmed by gel 
electrophoresis using 5 µl of the amplification reaction mixture 
on a 1% (w/v) agarose gel containing 1× SYBR® Safe (Invitrogen, 
Thermo Fisher Scientific, Waltham, MA, USA). Five microliters 
of these PCR products were taken to add adaptors and a 8-nt 
sample-specific barcode in an additional 5 cycle PCR amplifica-
tion. This second PCR was performed in a total volume of 100 µl 
containing 1× HF buffer, dNTP Mix, 2 U of Phusion® Hot Start II 
High-Fidelity DNA polymerase, 500 nM of a forward and reverse 
primer equivalent to the Unitag1 and UniTag2 sequences, respec-
tively, that were each appended with an 8 nt sample-specific bar-
code (G. Hermes and J. Ramiro-Garcia, et al., in preparation) at 
the 5′ end. PCR products were purified with the magnetic beads 
(MagBio, London, UK) according to the HighPrepTM protocol 
of the manufactures instructions using 20 µl nuclease-free water 
(Promega Leiden, the Netherlands) and quantified using the 
Qubit (Life Technologies, Bleiswijk, the Netherlands). Purified 
PCR products were mixed in approximately equimolar amounts 
and concentrated by the magnetic beads as the purification before. 
Purified amplicon pools were 250 bp paired-end sequenced using 
Illumina Miseq (GATC-Biotech, Konstanz, Germany).
The Illumina Miseq data analysis was carried out with a work-
flow employing the Quantitative Insights Into Microbial Ecology 
(QIIME) pipeline (21) and a set of in-house scripts as described 
before for Illumina Hiseq 16S rRNA gene sequences (G. Hermes 
and J. Ramiro-Garcia, et al., in preparation). The set of in-house 
scripts processed the reads as follows: reads were filtered for not 
matching barcodes; OTU picking and chimera removal was done 
via matching the sequences to the Silva 111 database, with only 
one mismatch allowed, and a biom and with ClustalW a multiple 
alignment and phylogenetic tree file was generated. Further 
outputs were generated via QIIME, such as filtered reads per 
sample, PD whole tree diversity measurements and the level 1 to 
6 taxonomic distributions with relative abundances.
statistics
Flow cytometry data and serum antibody isotype data are 
expressed as means. To verify whether data were normally 
distributed the Kolmogorov–Smirnov test was performed. In 
cases where data were not normally distributed, data were log 
FigUre 1 | Feces of conventional (conv) males (M) or females (F) was transferred to germ-free (GF) male or female recipient mice (n = 10) by oral gavage. Weight 
was measured once a week for 4 weeks and is presented as the percentage of the original weight just before gut microbiota transfer. * indicates p < 0.05,  
** indicates p < 0.01, and *** indicates p < 0.001.
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transformed before analysis. For comparing two groups, the 
unpaired two-tailed Student’s t-test was used. For comparing 
more than two groups with each other, one way ANOVA was 
performed followed by the Bonferroni test to compare specific 
groups. p-Values below 0.05 were considered significant, and 
p-values below 0.1 were considered a trend. All tests were per-
formed with GraphPad software (Prism, La Jolla, CA, USA).
Differentially expressed probe sets were identified using 
linear models, applying moderated T-statistics that implemented 
empirical Bayes regularization of SEs (22). A Bayesian hierar-
chical model was used to define an intensity-based moderated 
T-statistic, which takes into account the degree of independence 
of variances relative to the degree of identity and the relationship 
between variance and signal intensity (23).
Statistical tests for gut microbiota composition were per-
formed using R and Calypso (24). Where the count data were 
not normally distributed and variances between groups were not 
equal, the Mann–Whitney U test was used.
resUlTs
Male Microbiota induces lower Weight  
in Female Mice
In order to investigate how gender influences the interplay 
between the gut microbiota and the immune system of the host, 
we transferred gut microbiota from male or female conventional 
mice to GF mice of the same or opposing gender. After microbiota 
transfer, the weight of the GF recipient mice was followed for 
4 weeks. All GF recipient mice lost some weight in the first week 
after the microbiota transfer (Figure  1). However, GF females 
that received male microbiota had lost significantly more weight 
(p < 0.05) compared to GF females with female microbiota. The 
weight of the female recipients of a male microbiota developed 
in a similar fashion as the male recipients of male microbiota. 
This weight difference remained until the end of the experiment 
(p < 0.01). A gender-dependent effect of the microbiota on weight 
was not observed in male GF recipients.
FigUre 2 | Cells from thymus, spleen, Peyer’s patches (PPs), and mesenteric lymph nodes (MLNs) were analyzed with flow cytometry. Germ-free (GF) males (M) 
(n = 5), GF females (F) (n = 5), conventional (conv) males (n = 8), and females (n = 10) were included as controls. Experimental groups of GF recipients of gut 
microbiota each contained 10 mice per group. (a) Total number of thymus cells. (B) Percentage among live thymus cells of lineage negative (CD11b, CD11c, CD19, 
CD45R/B220, NK1.1, and TER119) cells that were also double negative (DN) for CD4 and CD8. (c) Absolute numbers of thymus cells that were lineage negative 
(CD11b, CD11c, CD19, CD45R/B220, NK1.1, and TER119) and also DN for CD4 and CD8. (D) Percentage of RORyt+Foxp3+ cells among CD4+ T cells in PPs.  
(e) Percentage of RORyt+Foxp3+ cells among CD4+ T cells in MLN. (F) Percentage of CD25+Foxp3+ regulatory cells (Treg) among CD4+ T cells in MLN. * indicates 
p < 0.05, ** indicates p < 0.01, and *** indicates p < 0.001.
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Female Microbiota enhances T cell 
Precursors in Thymus but lowers rOryt+ 
Foxp3+ T cells in Male recipients
Four weeks after microbiota transfer the mice were sacrificed and 
cells were isolated from the thymus, spleen, PPs, and MLNs to 
study the effect of the gut microbiota transfer on T cell develop-
ment and differentiation. Conventional and GF mice of both 
genders were included as controls. Male conventional mice had a 
higher number of thymic cells than germ-free males (p < 0.05). 
In addition, both conventional and GF females had a higher num-
ber of thymic cells (p < 0.01) compared to males (Figure 2A). 
Intriguingly, female recipients of female microbiota also had 
significantly more thymic cells (p < 0.05) than female recipients 
of male microbiota (Figure 2A). There was no gender-dependent 
effect of the microbiota on thymic cells in male recipients.
Early T  cell precursors in the thymus are DN for CD4 and 
CD8, after which they become double positive for CD4 and 
CD8, and finally develop into cells single positive for one of these 
molecules (25). Frequencies of DN T cell precursors tended to be 
higher in females (Figure 2B). Moreover, absolute numbers of 
DN T cell precursors were significantly higher (p < 0.001) in con-
ventional and GF females compared to males (Figure 2C). This 
higher number of DN T-cells was present in female microbiota 
recipients (both male and female) compared to recipients of male 
microbiota (p < 0.05). Taken together these results suggest that 
the gut microbiota influences T cell development in a gender-
dependent manner.
To study the impact of the gut microbiota on T cell differentia-
tion, the composition of the different CD4+ Th subsets were stud-
ied in the PPs, MLN, and the spleen. The frequency of the recently 
described RORγt+ Foxp3+ population (26) was much lower in the 
PPs (Figure 2D) and MLN (Figure 2E) of GF mice. Moreover, 
transfer of male microbiota led to a significantly higher percent-
age of RORγt+ Foxp3+ cells in PPs and MLN (p <  0.05) com-
pared to male recipients of female microbiota (Figures 2D–E). 
Frequencies of conventional Tregs were also higher (p < 0.001) 
in male recipients compared to female recipients, but this was 
not dependent on the microbiota (Figure  2F). No differences 
between the experimental groups were observed for the Th1, Th2, 
or Th17 subsets in any of the organs tested (Figure S1).
Microbiota influences antibody 
Production in a gender-specific Manner
To study the effect of microbial colonization on antibody produc-
tion, total levels of the different antibody isotypes were measured 
in the serum (Figure 3). GF females tended to have higher levels 
FigUre 3 | Total levels of IgM, IgG3, IgG2b, IgG2a, IgG1, IgE, and IgA were measured with luminex in serum of germ-free (GF) males (M) (n = 5), GF females  
(F) (n = 5), conventional (conv) males (n = 8), conventional females (n = 10), and the GF recipient male or female mice that received the gut microbiota from the 
same or opposite gender (n = 10 per group). * indicates p < 0.05.
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of IgM (p < 0.1) and significantly higher levels of IgE (p < 0.05) 
compared to GF males. These data suggest that females intrinsi-
cally produce higher levels of these antibody isotypes compared 
to males independent of the microbiota. Moreover, conventional 
females did not have different levels of any antibody isotype 
compared to GF females, which might suggest that in females gut 
microbiota did not influence antibody production in the systemic 
compartment. On the other hand, conventional males tended to 
have higher levels of IgM (p < 0.1) and significant higher levels 
of IgG2a and IgG2b (p < 0.05) compared to GF males (Figure 3). 
Thus gut microbiota seemed to influence antibody production 
in males but not in females. Interestingly, the female microbiota 
significantly (p <  0.05) lowered IgA levels compared to male 
microbiota in male GF recipients.
Microbiota-independent and Dependent 
Differences in gender-specific immunity
To determine microbiota-dependent and -independent differ-
ences in gender-specific immunity in the intestine, we performed 
genome-wide gene expression analysis of the ileum with microar-
ray. Ileum was chosen because of its primary intestinal role in 
immune signaling (6). Data were analyzed with Ingenuity Pathway 
Analysis (IPA), only focusing on genes that were significantly 
differentially expressed (p < 0.05, fold change >1.2 or <−1.2).
The microbiota-independent differences were studied by 
comparing gender-specific differences in GF animals and con-
ventional mice. A number of genes were identified that were 
exclusively expressed in females (Xist) or in males (Eif2s3y, Uty, 
Ddx3y, Kdm5d). This difference was similar between conventional 
(Figure 4A) and GF mice (Figure 4D). Canonical pathways that 
were differentially regulated in different genders in conventional 
mice included “estrogen biosynthesis,” but also immune path-
ways such as “TGF-β signaling” and “T cell receptor signaling” 
(Figure  4B). The prediction by IPA of the pro-inflammatory 
cytokine IL-1 β as the most significant upstream regulator fur-
ther confirmed the prominent differences in immunity between 
conventional males and females (Figure 4C).
Strikingly, the canonical pathways most significantly affected 
by gender in GF mice were all immune-related (Figure 4E). These 
pathways for example included “B cell development,” “Th cell dif-
ferentiation,” and “antigen presentation pathway.” This difference 
between GF males and females could be due to differences in the 
regulation of type I interferon (IFN) production, since the recep-
tor for type I IFN (IFNAR) and a transcription factor involved in 
type I IFN production (IRF7) were predicted as most significant 
upstream regulators by IPA (Figure 4F). In conclusion, some of 
the gender-dependent differences in immunity are not dependent 
on the gut microbiota, but are also present in GF mice.
To determine gender-specific microbiota effects, we compared 
ileal microarray data of (i) GF female recipient mice that received 
male or female microbiota and (ii) GF male recipient mice that 
received male or female microbiota.
In female recipients, the male microbiota upregulated several 
genes involved in the immune response, including a number of 
immunoglobulin variants, Dennd1b and Lcn2 (27–29) (Figure 5A). 
Female microbiota in GF females resulted in different effects. 
Here, the most highly upregulated genes were proteases Mcpt1 
and Mcpt2, which are expressed by intestinal mucosal mast cells 
(30). Most canonical pathways that were significantly affected by 
the gender of the microbiota in GF recipients mice were involved 
in DNA repair and the cell cycle (Figure 5B). Moreover, the most 
FigUre 4 | Microbiota-independent differences in immunity between males and females. Whole-genome gene expression in the ileum of male and female 
conventional (conv) mice (n = 5 per group) or male and female germ-free (GF) mice (n = 4) was assessed with Affymetrix GeneChip Mouse Gene 1.1 ST arrays. 
Genes that were significantly differentially expressed (p < 0.05 and fold change >1.2) between males and females, either conventional or germ free were analyzed 
with Ingenuity Pathway Analysis. (a) Top 10 of most upregulated genes and top 10 of most downregulated genes by comparing conventional males with 
conventional females. (B) Canonical pathways that were most significantly affected by gender in conventional mice. (c) Most significantly predicted upstream 
regulators of the pathways affected by gender in conventional mice. (D) Top 10 of most upregulated genes and top 10 of most downregulated genes by comparing 
GF males with GF females. (e) Canonical pathways that were most significantly affected by gender in GF mice. (F) Most significantly predicted upstream regulators 
of the pathways affected by gender in GF mice.
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significant predicted upstream regulator of these pathways was 
dextran sulfate (Figure  5C), which is a well-known inducer of 
experimental colitis (31).
In male recipients of female microbiota, the most highly 
upregulated genes included genes with known roles in the 
immune response, but also metabolism, including Cfd and Retn 
(32, 33) (Figure 5D). The most highly upregulated genes by the 
male microbiota in GF male recipients included Reg4, an antimi-
crobial protein recognized for its role in host–microbiota interac-
tions (34), and ADA, which is crucial for the development of the 
immune system (35). The most significantly affected canonical 
pathways by the gender of the microbiota in GF male recipients 
included “complement system,” “acute phase response signaling,” 
and “IL-10 signaling” (Figure 5E). The most significant predicted 
upstream regulators were rosiglitazone, which is used for the 
treatment of type 2 diabetes (36) and the pro-inflammatory 
cytokine TNF-α (Figure 5F).
Next, genes that were induced by the male microbiota both in 
male and female GF recipients, but not by the female microbiota 
in neither male nor female GF recipients, were analyzed with the 
STRING database (37). We identified a number of gene clusters 
specifically induced by the male microbiota, which are signifi-
cantly predicted to be involved in the gene ontology biological 
processes DNA replication and the cell cycle (Figure 6). A similar 
analysis of the response induced by the female microbiota did not 
reveal any clusters or pathways that were significantly affected 
(data not shown).
Bacterial groups associated With gender-
specific Microbiota Differences
To investigate how the gut microbiota composition changes over 
time in the recipient mice, composition of the gut microbiota of 
the different experimental groups was analyzed with 16S rRNA 
FigUre 5 | Microbiota-dependent differences in gender-specific immunity. Whole-genome gene expression in the ileum of male and female germ-free (GF) mice 
(n = 5) that received the gut microbiota from male or female conventional mice was assessed with Affymetrix GeneChip Mouse Gene 1.1 ST arrays. Genes that were 
significantly differentially expressed (p < 0.05 and fold change >1.2) between recipients of male and female microbiota were analyzed with Ingenuity Pathway 
Analysis. (a) Top 10 of most upregulated genes and top 10 of most downregulated genes by comparing male microbiota with female microbiota in GF female 
recipients. (B) Canonical pathways that were most significantly affected by gender of the microbiota in GF female recipient mice. (c) Most significantly predicted 
upstream regulators of the pathways affected by gender of the microbiota in GF female recipient mice. (D) Top 10 of most upregulated genes and top 10 of most 
downregulated genes by comparing female microbiota with male microbiota in GF male recipients. (e) Canonical pathways that were most significantly affected  
by gender of the microbiota in GF male recipient mice. (F) Most significantly predicted upstream regulators of the pathways affected by gender of the microbiota  
in GF male recipient mice.
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gene sequencing. From the male and female conventional mice, 
we analyzed feces at the time of transfer or 4 weeks after transfer 
(Figure 7). From the GF recipient mice, we analyzed feces 1 week 
after transfer or 4 weeks after transfer. A fundamental question to 
answer was whether the gut microbiota evolves into a community 
similar to the donor or whether it adapts to its host. Redundancy 
analysis (RDA) at the genus level confirmed that gut microbiota 
composition was different between male conventional mice and 
female conventional mice, since the samples separated into two 
distinct clusters at the time of transfer and 4 weeks after transfer 
(Figure 8A). One or four weeks after transfer of male or female 
microbiota to GF mice of both genders, four separate clusters of 
each experimental group could be distinguished (Figure  8A). 
These results imply that both the donor and host shape the 
gut microbiota community, leading to a unique composition 
in each experimental group. To further investigate how the gut 
microbiota communities from the different groups were related 
to each other, we performed another RDA analysis including all 
the groups and time points (Figure 8B) Surprisingly, this analysis 
revealed that for both genders the microbiota first adapted to the 
gender of the recipient 1 week after the transfer, but 4 weeks after 
the transfer gut microbiota composition was similar to the gender 
of the donor, regardless the gender of the recipient.
To study more specifically the bacterial groups that were 
potentially responsible for the observed differences in immune 
responses, we investigated which bacterial groups had a signifi-
cant difference in abundance at the family level (Figure 9A) or 
genus level (Figure 9B). Conventional females had higher abun-
dance of Desulfovibrionaceae, Lactobacillaceae (Lactobacillus at 
the genus level), and Verrucomicrobiaceae (Akkermansia at the 
genus level), whereas conventional males had higher abundance 
of Ruminococcaceae and Rikenellaceae (Alistipes at the genus 
FigUre 6 | Male microbiota influences DNA replication and the cell cycle. Whole-genome gene expression in the ileum of male and female germ-free (GF) mice 
(n = 4), or male and female GF recipient mice (n = 5) that received the gut microbiota from male or female conventional mice was assessed with Affymetrix 
GeneChip Mouse Gene 1.1 ST arrays. Only genes that were significantly differentially expressed (p < 0.05 and fold change >1.2) were included in the analysis. 
Genes that were specifically affected by the male microbiota were selected as follows: affected by male microbiota in male GF recipients compared to male GF 
controls AND affected by male microbiota in female GF recipients compared to female GF controls, but NOT affected by female microbiota in female GF recipients 
compared to female GF controls, OR female microbiota in male GF recipients compared to male GF controls. The resulting list of genes was analyzed with the 
STRING database. Only genes with at least one interaction are shown. The following interactions are indicated: from curated databases (blue), experimentally 
determined (pink), textmining (yellow), co-expression (black), and protein homology (purple).
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level). One week after transfer to GF recipients, the strong 
influence of the gender of the recipient was very clear, since all 
significant differences were dependent on the gender of the host. 
Female recipients had higher abundance of Lactobacillaceae 
(Lactobacillus at the genus level) and male recipients had higher 
abundance of Desulfovibrionaceae, Ruminococcaceae, and Por-
phyromonadaceae (Odoribacter at the genus level). Four weeks 
after transfer, most differences were still dependent on the 
gender of the host, but there were also some donor-dependent 
differences. For example, lactobacilli were still more abundant 
in female recipients, whereas Akkermansia and Prevotellaceae 
were more abundant in male recipients. However, in particular 
in GF female recipients, there was also a clear influence of the 
gender of the donor. In these mice, Rikenella, Lachnospiraceae, 
and Desulfovibrionaceae were increased after transfer of male 
microbiota, but Prevotellaceae was increased after transfer of the 
female microbiota.
DiscUssiOn
Several studies have demonstrated that gender influences gut 
microbiota composition (8–11) and the immune system (1–5). 
However, whether the differences in gut microbiota composition 
between males and females are a cause or consequence of gender-
specific differences in the immune system is not known. Here, we 
demonstrate that some characteristics of gender-specific immune 
differences can be induced by the gut microbiota.
Some differences in the immune system between males and 
females were also present in GF mice, suggesting these differences 
were not dependent on the gut microbiota. In particular, the type 
I IFN pathway was enhanced in the intestine of GF females. This 
can explain several gender-effects reported in literature. It has 
been shown that plasmacytoid DCs of females produce higher 
levels of IFN-α after TLR7 activation compared to males (38, 39). 
Furthermore, type I IFN has been shown to regulate intestinal 
FigUre 7 | Gut microbiota composition in conventional and conventionalized mice. Fecal samples were collected from conventional (conv) males (M) (n = 8) and 
conventional females (F) (n = 10) at the time of transfer or 4 weeks after transfer to the germ-free (GF) recipient mice. In addition, fecal samples 1 and 4 weeks after 
the transfer were collected from the following groups (all n = 10 per group): male GF recipient mice that received male microbiota (M + M), female GF recipient mice 
that received male microbiota (F + M), male GF recipient mice that received female microbiota (M + F), and female GF recipient mice that received female microbiota 
(F + F). Gut microbiota composition was analyzed with 16S rDNA sequencing and data are presented as the relative abundance of the different bacterial groups for 
each individual mouse. The most highly abundant bacterial groups are indicated.
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homeostasis (40). For example, mice with conditional deletion of 
the type I IFN receptor (IFNAR1) in intestinal epithelial cells had 
an altered gut microbiota composition, which promoted epithe-
lial hyperproliferation and experimental colitis-associated cancer 
(41). Therefore, it is conceivable that our observed enhanced type 
I IFN production in female intestines contributed to the selection 
of a gender-specific gut microbiota composition.
Interestingly, several bacterial groups, such as Alistipes, 
Rikenella, and Porphyromonadaceae, known to expand in the 
absence of innate immune defense mechanisms were over-
represented in the male microbiota in our study before or after 
transfer to GF mice. This is corroborated by the observation that 
Rikenellaceae and Porphyromonadaceae were more abundant 
in the gut microbiota of MyD88-deficient mice also lacking 
adequate innate immunity (42). Moreover, NOD2-deficiency 
has been shown to cause dysbiosis in mice, including a higher 
abundance of Rikenella, which induced transmissible colitis and 
colorectal cancer (43). Finally, in mice deficient in IL-10 and the 
antimicrobial peptide Lipocalin-2, Alistipes was shown to flourish 
and was sufficient to induce colitis and tumorigenesis in IL-10 
deficient mice (44). Notably, Lipocalin-2 was among the genes 
that were most highly upregulated in female recipients of male 
microbiota in our study. In summary, these results may indicate 
that a lower innate immune response in the gut of males pro-
moted growth of specific bacteria with the potential to promote 
intestinal inflammation.
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Several lines of evidence suggest that in our study the male 
microbiota induced more gut inflammation after transfer. Female 
recipients lost significantly more weight after receiving male 
microbiota compared to female microbiota. Weight loss is a sign 
of discomfort and a hallmark of dextran sulfate sodium (DSS)-
induced colitis (31). Interestingly, DSS was also most significantly 
predicted as upstream regulator when comparing gene expression 
in the ileum of female recipients of male or female microbiota. 
We also observed that DNA repair and cell cycle pathways were 
specifically induced by the male microbiota. This response could 
be due to increased inflammation induced by the male micro-
biota, since inflammation was previously shown to promote DNA 
damage and subsequent carcinogenesis in the colon (45).
The gut microbiota also influenced T  cell precursors in the 
thymus and T cell differentiation in PPs and MLN in a gender-
specific manner. We found that the thymus of females contained 
more cells compared to males. This corroborates the observation 
that thymus size is influenced by sex hormones and is larger 
in females (46). However, to our knowledge, we are the first to 
show that thymus size is also influenced by the gut microbiota 
in a gender-specific manner. In addition, the female microbiota 
induced less RORyt+Foxp3+ T  cells in PPs and MLN in male 
recipients compared to the male microbiota. This cell popula-
tion has recently been shown to be induced by the microbiota 
and to inhibit Th2-associated pathology (26). Thus, the female 
microbiota might be less efficient in preventing allergies. Indeed 
FigUre 8 | Redundancy analysis (RDA) of gut microbiota composition. Fecal samples were collected from conventional (conv) males (M) (n = 8) and conventional 
females (F) (n = 10) at the time of transfer or 4 weeks after transfer to the germ-free (GF) recipient mice. In addition, fecal samples 1 and 4 weeks after the transfer 
were collected from the following groups (all n = 10 per group): male GF recipient mice that received male microbiota (male microbiota male), female GF recipient 
mice that received male microbiota (male microbiota female), male GF recipient mice that received female microbiota (female microbiota male), and female GF 
recipient mice that received female microbiota (female microbiota female). Gut microbiota composition was analyzed with 16S rRNA gene sequencing. (a) RDA of 
gut microbiota composition of conventional males and females at the time of transfer (first panel), or conventional males and females 4 weeks after transfer  
(second panel), or GF recipient mice 1 week after transfer (third panel), or GF recipient mice 4 weeks after transfer (fourth panel). (B) RDA of gut microbiota 
composition of all groups combined.
12
Fransen et al. Gender, Gut Microbiome, and Immunity
Frontiers in Immunology | www.frontiersin.org June 2017 | Volume 8 | Article 754
IgE-mediated food allergies are known to be more prevalent in 
adult females (47).
Together our results suggest that microbiota-independent 
gender immune differences contribute to the selection of a 
gender-specific gut microbiota composition, which in turn fur-
ther drives gender immune differences. Therefore, gender should 
be considered in the development of strategies to target the gut 
microbiota in different disorders.
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FigUre s1 | Cells from spleen, Peyer’s patches (PPs), and mesenteric lymph 
nodes (MLNs) were analyzed with flow cytometry. Germ-free (GF) males (M) 
(n = 5), GF females (F) (n = 5), conventional (conv) males (n = 8), and females 
(n = 10) were included as controls. Experimental groups of GF recipients of gut 
microbiota each contained 10 mice per group. (a) Percentage of RORyt+Foxp3+ 
cells among CD4+ T cells in the spleen. (B) percentage of CD25+Foxp3+ 
regulatory cells (Treg) among CD4+ T cells in the spleen and PPs. (c) Percentage 
of T-bet+ Th1 cells among CD4+ T cells in the spleen, MLNs, and PPs.  
(D) Percentage of Roryt+ Th17 cells among CD4+ T cells in the spleen, MLNs, 
and PPs. (e) Percentage of Gata-3+ Th2 cells among CD4+ T cells in the spleen, 
MLNs, and PPs.
FigUre 9 | Gender-specific differences in gut microbiota composition. Fecal samples were collected from conventional (conv) males (M) (n = 8) and conventional 
females (F) (n = 10) at the time of transfer or 4 weeks after transfer to the germ-free (GF) recipient mice. In addition, fecal samples 1 and 4 weeks after the transfer 
were collected from the following groups (all n = 10 per group): male GF recipient mice that received male microbiota (male microbiota male), female GF recipient 
mice that received male microbiota (male microbiota female), male GF recipient mice that received female microbiota (female microbiota male), and female GF 
recipient mice that received female microbiota (female microbiota female). Gut microbiota composition was analyzed with 16S rRNA gene sequencing. (a) Bacterial 
families that were significantly different in abundance in the different experimental groups. (B) Bacterial genera that were significantly different in abundance in the 
different experimental groups.
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